Back to MA Mirae Asset Global Investments Co., Ltd.

IMVT

18 quarters

Position history for MAMirae Asset Global Investments Co., Ltd.'s holdings in Immunovant, Inc.

Yes. Mirae Asset Global Investments holds 10,555 shares of IMVT (Immunovant), worth $356,548, as of its Q3 2026 13F filing. It increased the position by 1,373 shares (+15.0%) from Q2 2026. Mirae Asset Global Investments has held IMVT since Q2 2022, across 18 quarterly 13F filings.

Current Value

$356,548

Current Shares

10,555

Total Value Change

+$299,548

Total Shares Change

-3,977

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q3
Latest
Increased
10,555
+14.9%
$356,5480.0%$33.78
27
2026-Q2
Decreased
9,182
-13.5%
$353,7820.0%$38.53
0
2026-Q1
Increased
10,616
+24.6%
$263,7010.0%$24.84
28
2025-Q4
Increased
8,517
+26.4%
$216,5020.0%$25.42
28
2025-Q3
Increased
6,739
+2.1%
$108,6330.0%$16.12
22
2025-Q2
Increased
6,603
+11.4%
$105,6480.0%$16.00
24
2025-Q1
Increased
5,928
+21.2%
$108,8970.0%$17.09
26
2024-Q4
Decreased
4,891
-7.6%
$119,7810.0%$24.77
0
2024-Q3
Increased
5,294
+21.4%
$148,3380.0%$28.02
27
2024-Q2
Decreased
4,360
-93.9%
$113,3600.0%$26.40
0
2024-Q1
Increased
71,788
+98.3%
$1.3M0.0%$32.31
41
2023-Q4
Decreased
36,199
-3.2%
$1.5M0.0%$42.13
0
2023-Q3
Increased
37,401
+2.9%
$1.4M0.0%$38.39
26
2023-Q2
Decreased
36,342
-51.1%
$685,5350.0%$18.52
0
2023-Q1
Increased
74,372
+226.5%
$1.2M0.0%$15.47
41
2022-Q4
Increased
22,779
+16.4%
$404,3280.0%$17.75
28
2022-Q3
Increased
19,572
+34.7%
$109,0000.0%$5.38
28
2022-Q2
New
14,532
-
$57,0000.0%$3.90
29

Other major holders of IMVT: FMR LLC, RTW Investments, LP

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used